Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
eWeLL CoTSE:5038 -0.51%74 EV-to-EBIT is 15.83 as of Sep. 09, 2026, which is 49% below its 10-year median of 31.19. GuruFocus rates TSE:5038 with a GF Score™ of 74/100 and a GF Value™ of 円3,224.11 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 476 Healthcare Providers & Services companies, eWeLL Co ranks worse than 52.52% on this metric.
The historical rank and industry rank for eWeLL Co's EV-to-EBIT or its related term are showing as below:
TSE:5038'
s EV-to-EBIT Range Over the Past 10 Years
Min: 14.78 Med: 31.19 Max: 162.35
Current: 15.83
During the past 6 years, the highest EV-to-EBIT of eWeLL Co was 162.35. The lowest was 14.78. And the median was 31.19.
TSE:5038's EV-to-EBIT is ranked worse than 52.52% of 476
companies
in the Healthcare Providers & Services industry
Industry Median: 15.155
vs TSE:5038: 15.83
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
eWeLL Co's Enterprise Value for the quarter that ended in Jun. 2026 was 円22,221 Mil.
eWeLL Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円1,708 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
eWeLL Co EV-to-EBIT Related Terms
eWeLL Co EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for eWeLL Co's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:5038 vs VEEV, BTSG, TEM: EV-to-EBIT Comparison
For the Health Information Services subindustry, eWeLL Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
eWeLL Co EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, eWeLL Co's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where eWeLL Co's EV-to-EBIT falls into.
eWeLL Co's current Enterprise Value is 円27,038 Mil.
eWeLL Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円1,708 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
eWeLL Co (TSE:5038) has a EV-to-EBIT of 15.83 as of Sep. 09, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on eWeLL Co and its competitors. This is 49% below median its historical median of 31.19. Over the past decade, eWeLL Co's EV-to-EBIT has ranged from 14.78 to 162.35. According to the industry distribution chart, eWeLL Co ranks #250 out of 476 companies in the Healthcare Providers & Services industry, placing it in the top 52.5%.
Is eWeLL Co's EV-to-EBIT too high?
eWeLL Co's current EV-to-EBIT of 15.83 is 49% below median its 10-year median of 31.19. Over the past 10 years, this metric has ranged from a low of 14.78 to a high of 162.35. The Healthcare Providers & Services industry median EV-to-EBIT is 15.16. eWeLL Co's value of 15.83 is 4.5% above this industry median. Based on the distribution chart, eWeLL Co ranks #250 out of 476 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, eWeLL Co has a GF Score™ of 74/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does eWeLL Co's EV-to-EBIT compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, eWeLL Co ranks #250 out of 476 companies for EV-to-EBIT. This places eWeLL Co in the lower half of its industry. The industry median EV-to-EBIT is 15.16. eWeLL Co's value of 15.83 is 4.5% above this benchmark. Historically, eWeLL Co's own EV-to-EBIT has ranged from 14.78 to 162.35 over the past decade. While the company's 10-year median is 31.19 vs. the industry median of 15.16, eWeLL Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.16, based on 476 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. eWeLL Co's current EV-to-EBIT of 15.83 is 4.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on eWeLL Co and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. eWeLL Co's current EV-to-EBIT is 15.83, which is 49% below median its own 10-year median of 31.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is eWeLL Co stock overvalued right now?
Based on GuruFocus' analysis, eWeLL Co (TSE:5038) is currently considered Significantly Undervalued. The stock's GF Value™ is 円3,224.11, compared to a current price of 円2,140.00 — trading 33.6% below its estimated fair value. The current EV-to-EBIT is 15.83, which is 49% below median its 10-year median of 31.19 and 4.5% above the Healthcare Providers & Services industry median of 15.16. eWeLL Co's overall GF Score™ is 74/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For eWeLL Co (TSE:5038), the current EV-to-EBIT is 15.83 as of Sep. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is eWeLL Co (TSE:5038) Overvalued in 2026?
Based on GuruFocus' analysis, eWeLL Co stock appears to be undervalued.
The current stock price of 円2,140.00 is trading 33.6% below its estimated GF Value™ of 円3,224.11.
GuruFocus considers eWeLL Co to be Significantly Undervalued.
Key valuation signals for TSE:5038:
EV-to-EBIT: 15.83 (49% below median its 10-year median of 31.19)
GF Value™: 円3,224.11 vs. price of 円2,140.00 (33.6% below fair value)
Industry Position: 4.5% above the Healthcare Providers & Services median (#250 of 476)
No single metric tells the full story. See the TSE:5038 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
eWeLL Co Ltd provide services that support businesses in the home-based care industry such as SaaS business support tools for home-visit nursing stations.
74GF Score
Get the complete analysis for TSE:5038
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:5038 has been successfully added to your 
